Source link : https://newshealth.biz/health-news/maintenance-regimens-expand-in-her2-positive-metastatic-breast-cancer/
At the American Society of Clinical Oncology (ASCO) meeting, updated HER2CLIMB-05 findings on the addition of tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) added to a growing conversation about maintenance strategies in HER2-positive metastatic breast cancer. In this exclusive MedPage Today video, Erika Hamilton, MD, of the Sarah Cannon Research […]
The post Maintenance Regimens Expand in HER2-Positive Metastatic Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-16 17:53:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8